comparemela.com
Home
Live Updates
Heart Allograft Transplantation - Breaking News
Pages:
Latest Breaking News On - Heart allograft transplantation - Page 1 : comparemela.com
Tonix Pharmaceuticals : Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress - Form 8-K
Tonix Pharmaceuticals Holding Corp. , a clinical-stage biopharmaceutical company, today announced data from three oral presentations at the 2022 American Transplant Congress by faculty at the Center. | June 9, 2022
United states
Jessica morris
Seth lederman
Olipriya das
Peter vozzo
Tonix pharmaceuticals
Tonix pharmaceuticals announces data presentations involving
Exchange commission
Transplantation sciences
Tonix pharmaceuticals holding corp
American transplant congress
Faculty of the center
Heart allograft transplantation
Animal models
Massachusetts general
Pharmaceuticals holding
vimarsana © 2020. All Rights Reserved.